Author:
Pal* Anupama,Huang* Wei,Kleer Celina G.
Reference38 articles.
1. Allen N.E., Roddam A.W., Allen D.S., Fentiman I.S., Dos Santos Silva I., Peto J. et al. (2005). A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92: 1283–1287.
2. Benini S., Perbal B., Zambelli D., Colombo M.P., Manara M.C., Serra M. et al. (2005). In Ewing’s sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24: 4349–4361.
3. Byrne C., Colditz G.A., Willett W.C., Speizer F.E., Pollak M., Hankinson S.E. (2000). Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60: 3744–3748.
4. Byun D., Mohan S., Baylink D.J., Qin X. (2001). Localization of the IGF binding domain and evaluation of the role of cysteine residues in IGF binding in IGF binding protein-4. J Endocrinol 169: 135–143.
5. Carboni J.M., Lee A.V., Hadsell D.L., Rowley B.R., Lee F.Y., Bol D.K. et al. (2005). Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65: 3781–3787.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献